Detail Information of Post-Translational Modifications

General Information of Drug Transporter (DT)
DT ID	DTD0060 Transporter Info
Gene Name	ABCC7
Transporter Name	Cystic fibrosis transmembrane conductance regulator
Gene ID	1080
UniProt ID	P13569

Post-Translational Modification of This DT
Overview of ABCC7 Modification Sites with Functional and Structural Information
Sequence	M Q R S P L E K A S V V S K L F F S W T R P I L R K G Y R Q R L E L S D I Y Q I P S V D S A D N L S E K L E R E W D R E L A S K K N P K L I N A L R R C F F W R F M F Y G I F L Y L G E V T K A V Q P L L L G R I I A S Y D P D N K E E R S I A I Y L G I G L C L L F I V R T L L L H P A I F G L H H I G M Q M R I A M F S L I Y K K T L K L S S R V L D K I S I G Q L V S L L S N N L N K F D E G L A L A H F V W I A P L Q V A L L M G L I W E L L Q A S A F C G L G F L I V L A L F Q A G L G R M M M K Y R D Q R A G K I S E R L V I T S E M I E N I Q S V K A Y C W E E A M E K M I E N L R Q T E L K L T R K A A Y V R Y F N S S A F F F S G F F V V F L S V L P Y A L I K G I I L R K I F T T I S F C I V L R M A V T R Q F P W A V Q T W Y D S L G A I N K I Q D F L Q K Q E Y K T L E Y N L T T T E V V M E N V T A F W E E G F G E L F E K A K Q N N N N R K T S N G D D S L F F S N F S L L G T P V L K D I N F K I E R G Q L L A V A G S T G A G K T S L L M V I M G E L E P S E G K I K H S G R I S F C S Q F S W I M P G T I K E N I I F G V S Y D E Y R Y R S V I K A C Q L E E D I S K F A E K D N I V L G E G G I T L S G G Q R A R I S L A R A V Y K D A D L Y L L D S P F G Y L D V L T E K E I F E S C V C K L M A N K T R I L V T S K M E H L K K A D K I L I L H E G S S Y F Y G T F S E L Q N L Q P D F S S K L M G C D S F D Q F S A E R R N S I L T E T L H R F S L E G D A P V S W T E T K K Q S F K Q T G E F G E K R K N S I L N P I N S I R K F S I V Q K T P L Q M N G I E E D S D E P L E R R L S L V P D S E Q G E A I L P R I S V I S T G P T L Q A R R R Q S V L N L M T H S V N Q G Q N I H R K T T A S T R K V S L A P Q A N L T E L D I Y S R R L S Q E T G L E I S E E I N E E D L K E C F F D D M E S I P A V T T W N T Y L R Y I T V H K S L I F V L I W C L V I F L A E V A A S L V V L W L L G N T P L Q D K G N S T H S R N N S Y A V I I T S T S S Y Y V F Y I Y V G V A D T L L A M G F F R G L P L V H T L I T V S K I L H H K M L H S V L Q A P M S T L N T L K A G G I L N R F S K D I A I L D D L L P L T I F D F I Q L L L I V I G A I A V V A V L Q P Y I F V A T V P V I V A F I M L R A Y F L Q T S Q Q L K Q L E S E G R S P I F T H L V T S L K G L W T L R A F G R Q P Y F E T L F H K A L N L H T A N W F L Y L S T L R W F Q M R I E M I F V I F F I A V T F I S I L T T G E G E G R V G I I L T L A M N I M S T L Q W A V N S S I D V D S L M R S V S R V F K F I D M P T E G K P T K S T K P Y K N G Q L S K V M I I E N S H V K K D D I W P S G G Q M T V K D L T A K Y T E G G N A I L E N I S F S I S P G Q R V G L L G R T G S G K S T L L S A F L R L L N T E G E I Q I D G V S W D S I T L Q Q W R K A F G V I P Q K V F I F S G T F R K N L D P Y E Q W S D Q E I W K V A D E V G L R S V I E Q F P G K L D F V L V D G G C V L S H G H K Q L M C L A R S V L S K A K I L L L D E P S A H L D P V T Y Q I I R R T L K Q A F A D C T V I L C E H R I E A M L E C Q Q F L V I E E N K V R Q Y D S I Q K L L N E R S L F R Q A I S P S D R V K L F P H R N S S K C K S K P Q I A A L K E E T E E E V Q D T R L
PTM type	X-Deubiquitination X-Glutathionylation X-N-glycosylation X-Phosphorylation X-S-glutathionylation X-S-palmitoylation X-SUMOylation X-Ubiquitination X: Amino Acid

Deubiquitination
Unclear Residue	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Enhancing the endocytic recycling to the cell membrane of ABCC7			[1]
Role of PTM	Protein Activity Modulation
Related Enzyme	Ubiquitin carboxyl-terminal hydrolase 10 (USP10)
Experimental Material(s)	Human airway epithelial cells
Experimental Method	Co-Immunoprecipitation
Detailed Description	Deubiquitination at ABCC7 have been reported to enhance its endocytic recycling to the cell membrane.
Glutathionylation
Cystine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence ABCC7			[2] , [3]
Role of PTM	Potential impacts
Modified Residue	Cystine	Modified Location	1344
Experimental Method	Co-Immunoprecipitation
Detailed Description	Glutathionylation at ABCC7 Cystine 1344 has the potential to affect its expression or activity.
N-glycosylation
Asparagine	2 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence ABCC7			[4]
Role of PTM	Potential impacts
Modified Residue	Asparagine	Modified Location	894
Experimental Method	Co-Immunoprecipitation
Detailed Description	N-linked Glycosylation at ABCC7 Asparagine 894 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence ABCC7			[4]
Role of PTM	Potential impacts
Modified Residue	Asparagine	Modified Location	900
Experimental Method	Co-Immunoprecipitation
Detailed Description	N-linked Glycosylation at ABCC7 Asparagine 900 has the potential to affect its expression or activity.
Tyrosine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Affecting the activity of ABCC7			[5]
Role of PTM	Protein Activity Modulation
Modified Residue	Tyrosine	Modified Location	908
Modified State	Tyrosine to Asparagine substitution
Studied Phenotype	Cystic fibrosis [ICD11: CA25]
Experimental Material(s)	Baby hamster kidney (BHK) cells
Experimental Method	Co-Immunoprecipitation
Detailed Description	Removal of the N-glycosylation at ABCC7 Tyrosine 908 (i.e. Tyrosine to Asparagine substitution) have been reported to affect its transport activity.
Phosphorylation
Serine	32 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Regulating the cAMP-responsive Cl- channel activity of the transporter			[6]
Role of PTM	Conformational Change
Modified Residue	Serine	Modified Location	660
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCC7 Serine 660 have been reported to regulate its cAMP-responsive Cl- channel activity.
PTM Phenomenon 2	Regulating the cAMP-responsive Cl- channel activity of the transporter			[6]
Role of PTM	Conformational Change
Modified Residue	Serine	Modified Location	737
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCC7 Serine 737 have been reported to regulate its cAMP-responsive Cl- channel activity.
PTM Phenomenon 3	Regulating the cAMP-responsive Cl- channel activity of the transporter			[6]
Role of PTM	Conformational Change
Modified Residue	Serine	Modified Location	795
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCC7 Serine 795 have been reported to regulate its cAMP-responsive Cl- channel activity.
PTM Phenomenon 4	Regulating the cAMP-responsive Cl- channel activity of the transporter			[6]
Role of PTM	Conformational Change
Modified Residue	Serine	Modified Location	813
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCC7 Serine 813 have been reported to regulate its cAMP-responsive Cl- channel activity.
PTM Phenomenon 5	Impairing the function of ABCC7			[7]
Role of PTM	Protein Activity Modulation
Modified Residue	Serine	Modified Location	1045
Modified State	Serine to Tyrosine substitution
Studied Phenotype	Cystic fibrosis [ICD11: CA25]
Experimental Material(s)	Human embryonic kidney 293 (HEK293) cells
Experimental Method	Co-Immunoprecipitation
Detailed Description	Removal of the Phosphorylation at ABCC7 Serine 1045 (i.e. Serine to Tyrosine substitution) have been reported to impaire its transport function.
PTM Phenomenon 6	Have the potential to influence ABCC7			[8]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	4
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCC7 Serine 4 has the potential to affect its expression or activity.
PTM Phenomenon 7	Have the potential to influence ABCC7			[9]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	422
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCC7 Serine 422 has the potential to affect its expression or activity.
PTM Phenomenon 8	Have the potential to influence ABCC7			[10]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	466
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCC7 Serine 466 has the potential to affect its expression or activity.
PTM Phenomenon 9	Have the potential to influence ABCC7			[11]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	489
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCC7 Serine 489 has the potential to affect its expression or activity.
PTM Phenomenon 10	Have the potential to influence ABCC7			[11]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	492
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCC7 Serine 492 has the potential to affect its expression or activity.
PTM Phenomenon 11	Have the potential to influence ABCC7			[9] , [12]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	511
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCC7 Serine 511 has the potential to affect its expression or activity.
PTM Phenomenon 12	Have the potential to influence ABCC7			[13] , [14]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	549
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCC7 Serine 549 has the potential to affect its expression or activity.
PTM Phenomenon 13	Have the potential to influence ABCC7			[12] , [15]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	641
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCC7 Serine 641 has the potential to affect its expression or activity.
PTM Phenomenon 14	Have the potential to influence ABCC7			[13] , [16]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	670
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCC7 Serine 670 has the potential to affect its expression or activity.
PTM Phenomenon 15	Have the potential to influence ABCC7			[12] , [13]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	686
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCC7 Serine 686 has the potential to affect its expression or activity.
PTM Phenomenon 16	Have the potential to influence ABCC7			[13] , [16]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	700
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCC7 Serine 700 has the potential to affect its expression or activity.
PTM Phenomenon 17	Have the potential to influence ABCC7			[12] , [15]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	707
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCC7 Serine 707 has the potential to affect its expression or activity.
PTM Phenomenon 18	Have the potential to influence ABCC7			[13] , [16]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	712
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCC7 Serine 712 has the potential to affect its expression or activity.
PTM Phenomenon 19	Have the potential to influence ABCC7			[17]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	728
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCC7 Serine 728 has the potential to affect its expression or activity.
PTM Phenomenon 20	Have the potential to influence ABCC7			[13] , [16]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	753
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCC7 Serine 753 has the potential to affect its expression or activity.
PTM Phenomenon 21	Have the potential to influence ABCC7			[13] , [16]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	768
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCC7 Serine 768 has the potential to affect its expression or activity.
PTM Phenomenon 22	Have the potential to influence ABCC7			[18]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	776
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCC7 Serine 776 has the potential to affect its expression or activity.
PTM Phenomenon 23	Have the potential to influence ABCC7			[12] , [13]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	790
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCC7 Serine 790 has the potential to affect its expression or activity.
PTM Phenomenon 24	Have the potential to influence ABCC7			[8] , [19]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	809
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCC7 Serine 809 has the potential to affect its expression or activity.
PTM Phenomenon 25	Have the potential to influence ABCC7			[20] , [21]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	1248
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCC7 Serine 1248 has the potential to affect its expression or activity.
PTM Phenomenon 26	Have the potential to influence ABCC7			[22]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	1255
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCC7 Serine 1255 has the potential to affect its expression or activity.
PTM Phenomenon 27	Have the potential to influence ABCC7			[23]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	1359
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCC7 Serine 1359 has the potential to affect its expression or activity.
PTM Phenomenon 28	Have the potential to influence ABCC7			[12] , [23]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	1362
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCC7 Serine 1362 has the potential to affect its expression or activity.
PTM Phenomenon 29	Have the potential to influence ABCC7			[24]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	1426
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCC7 Serine 1426 has the potential to affect its expression or activity.
PTM Phenomenon 30	Have the potential to influence ABCC7			[13] , [25]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	1444
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCC7 Serine 1444 has the potential to affect its expression or activity.
PTM Phenomenon 31	Have the potential to influence ABCC7			[26]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	1455
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCC7 Serine 1455 has the potential to affect its expression or activity.
PTM Phenomenon 32	Have the potential to influence ABCC7			[13] , [27]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	1456
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCC7 Serine 1456 has the potential to affect its expression or activity.
Threonine	14 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence ABCC7			[12] , [23]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	291
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCC7 Threonine 291 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence ABCC7			[8] , [10]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	421
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCC7 Threonine 421 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence ABCC7			[11]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	501
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCC7 Threonine 501 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence ABCC7			[14]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	547
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCC7 Threonine 547 has the potential to affect its expression or activity.
PTM Phenomenon 5	Have the potential to influence ABCC7			[12] , [15]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	582
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCC7 Threonine 582 has the potential to affect its expression or activity.
PTM Phenomenon 6	Have the potential to influence ABCC7			[12] , [15]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	604
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCC7 Threonine 604 has the potential to affect its expression or activity.
PTM Phenomenon 7	Have the potential to influence ABCC7			[12] , [15]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	682
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCC7 Threonine 682 has the potential to affect its expression or activity.
PTM Phenomenon 8	Have the potential to influence ABCC7			[13] , [25]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	717
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCC7 Threonine 717 has the potential to affect its expression or activity.
PTM Phenomenon 9	Have the potential to influence ABCC7			[18]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	774
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCC7 Threonine 774 has the potential to affect its expression or activity.
PTM Phenomenon 10	Have the potential to influence ABCC7			[8] , [19]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	803
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCC7 Threonine 803 has the potential to affect its expression or activity.
PTM Phenomenon 11	Have the potential to influence ABCC7			[28]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	1171
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCC7 Threonine 1171 has the potential to affect its expression or activity.
PTM Phenomenon 12	Have the potential to influence ABCC7			[29]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	1176
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCC7 Threonine 1176 has the potential to affect its expression or activity.
PTM Phenomenon 13	Have the potential to influence ABCC7			[20] , [21]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	1246
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCC7 Threonine 1246 has the potential to affect its expression or activity.
PTM Phenomenon 14	Have the potential to influence ABCC7			[9]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	1471
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCC7 Threonine 1471 has the potential to affect its expression or activity.
Tyrosine	4 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence ABCC7			[9] , [30]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	512
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCC7 Tyrosine 512 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence ABCC7			[12] , [31]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	515
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCC7 Tyrosine 515 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence ABCC7			[19]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	808
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCC7 Tyrosine 808 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence ABCC7			[24]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	1424
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ABCC7 Tyrosine 1424 has the potential to affect its expression or activity.
S-glutathionylation
Cystine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence CFTR			[32]
Role of PTM	Potential impacts
Modified Residue	Cystine	Modified Location	1344
Experimental Method	Co-Immunoprecipitation
Detailed Description	S-glutathionylation (-SSG) at CFTR Cystine 1344 has the potential to affect its expression or activity.
S-palmitoylation
Cystine	2 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence ABCC7			[25]
Role of PTM	Potential impacts
Modified Residue	Cystine	Modified Location	524
Experimental Method	Co-Immunoprecipitation
Detailed Description	S-palmitoylation at ABCC7 Cystine 524 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence ABCC7			[25]
Role of PTM	Potential impacts
Modified Residue	Cystine	Modified Location	1395
Experimental Method	Co-Immunoprecipitation
Detailed Description	S-palmitoylation at ABCC7 Cystine 1395 has the potential to affect its expression or activity.
SUMOylation
Unclear Residue	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Enhancing the action of therapeutics that correct ABCC7 trafficking to the apical membranes			[33] , [34]
Role of PTM	Surface Expression Modulation
Experimental Method	Co-Immunoprecipitation
Detailed Description	SUMOylation at ABCC7 have been reported to enhance its action of therapeutics that correct the transporter trafficking to the apical membranes.
Ubiquitination
Lysine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence ABCC7			[25]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	688
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at ABCC7 Lysine 688 has the potential to affect its expression or activity.
Unclear Residue	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Decreasing the expression and function of ABCC7			[35]
Role of PTM	Trafficking to Plasma Membrane
Related Enzyme	NEDD4-binding protein 2-like 2 (N4BP2L2)
Experimental Material(s)	(MPP+)-treated astrocytes
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at ABCC7 have been reported to decrease its expression and transport function.

References
1	The deubiquitinating enzyme USP10 regulates the post-endocytic sorting of cystic fibrosis transmembrane conductance regulator in airway epithelial cells. J Biol Chem. 2009 Jul 10;284(28):18778-89.
2	RedoxDB--a curated database for experimentally verified protein oxidative modification. Bioinformatics. 2012 Oct 1;28(19):2551-2.
3	Reversible silencing of CFTR chloride channels by glutathionylation. J Gen Physiol. 2005 Feb;125(2):127-41.
4	Modulation of endocytic trafficking and apical stability of CFTR in primary human airway epithelial cultures. Am J Physiol Lung Cell Mol Physiol. 2010 Mar;298(3):L304-14.
5	A novel CFTR disease-associated mutation causes addition of an extra N-linked oligosaccharide. Glycoconj J. 2000 Nov;17(11):807-13.
6	Phosphorylation of the R domain by cAMP-dependent protein kinase regulates the CFTR chloride channel. Cell. 1991 Sep 6;66(5):1027-36.
7	Personalized medicine in cystic fibrosis: genistein supplementation as a treatment option for patients with a rare S1045Y-CFTR mutation. Am J Physiol Lung Cell Mol Physiol. 2016 Aug 1;311(2):L364-74.
8	Ischemia in tumors induces early and sustained phosphorylation changes in stress kinase pathways but does not affect global protein levels. Mol Cell Proteomics. 2014 Jul;13(7):1690-704.
9	Contribution of casein kinase 2 and spleen tyrosine kinase to CFTR trafficking and protein kinase A-induced activity. Mol Cell Biol. 2011 Nov;31(22):4392-404.
10	Integrated analysis of global proteome, phosphoproteome, and glycoproteome enables complementary interpretation of disease-related protein networks. Sci Rep. 2015 Dec 11;5:18189.
11	Global phosphoproteomic analysis reveals ARMC10 as an AMPK substrate that regulates mitochondrial dynamics. Nat Commun. 2019 Jan 10;10(1):104.
12	Systematic functional prioritization of protein posttranslational modifications. Cell. 2012 Jul 20;150(2):413-25.
13	UniProt: a worldwide hub of protein knowledge. Nucleic Acids Res. 2019 Jan 8;47(D1):D506-D515.
14	Quantitative analysis of a phosphoproteome readily altered by the protein kinase CK2 inhibitor quinalizarin in HEK-293T cells. Biochim Biophys Acta. 2015 Jun;1854(6):609-23.
15	Stimulatory and inhibitory protein kinase C consensus sequences regulate the cystic fibrosis transmembrane conductance regulator. Proc Natl Acad Sci U S A. 2004 Jan 6;101(1):390-5.
16	The major cystic fibrosis causing mutation exhibits defective propensity for phosphorylation. Proteomics. 2015 Jan;15(2-3):447-61.
17	Phosphoproteomics study on the activated PKC-induced cell death. J Proteome Res. 2013 Oct 4;12(10):4280-301.
18	Identification of missing proteins in the neXtProt database and unregistered phosphopeptides in the PhosphoSitePlus database as part of the Chromosome-centric Human Proteome Project. J Proteome Res. 2013 Jun 7;12(6):2414-21.
19	Phosphotyrosine-based-phosphoproteomics scaled-down to biopsy level for analysis of individual tumor biology and treatment selection. J Proteomics. 2017 Jun 6;162:99-107.
20	Mass spectrometric phosphoproteome analysis of small-sized samples of human neutrophils. Clin Chim Acta. 2015 Dec 7;451(Pt B):199-207.
21	Non-alcoholic fatty liver disease phosphoproteomics: A functional piece of the precision puzzle. Hepatol Res. 2017 Dec;47(13):1469-1483.
22	iTRAQ labeling is superior to mTRAQ for quantitative global proteomics and phosphoproteomics. Mol Cell Proteomics. 2012 Jun;11(6):M111.014423.
23	Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis. Sci Signal. 2010 Jan 12;3(104):ra3.
24	Phosphoproteomic Analysis of Aurora Kinase Inhibition in Monopolar Cytokinesis. J Proteome Res. 2015 Sep 4;14(9):4087-98.
25	Purification of CFTR for mass spectrometry analysis: identification of palmitoylation and other post-translational modifications. Protein Eng Des Sel. 2012 Jan;25(1):7-14.
26	Quantification of pancreatic cancer proteome and phosphorylome: indicates molecular events likely contributing to cancer and activity of drug targets. PLoS One. 2014 Mar 26;9(3):e90948.
27	Two Small Molecules Restore Stability to a Subpopulation of the Cystic Fibrosis Transmembrane Conductance Regulator with the Predominant Disease-causing Mutation. J Biol Chem. 2017 Mar 3;292(9):3706-3719.
28	Insights into chemoselectivity principles in metal oxide affinity chromatography using tailored nanocast metal oxide microspheres and mass spectrometry-based phosphoproteomics. Analyst. 2017 May 30;142(11):1993-2003.
29	Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach. Anal Chem. 2009 Jun 1;81(11):4493-501.
30	Antagonistic regulation of cystic fibrosis transmembrane conductance regulator cell surface expression by protein kinases WNK4 and spleen tyrosine kinase. Mol Cell Biol. 2011 Oct;31(19):4076-86.
31	Tyrosine phosphorylated Par3 regulates epithelial tight junction assembly promoted by EGFR signaling. EMBO J. 2006 Nov 1;25(21):5058-70.
32	dbGSH: a database of S-glutathionylation. Bioinformatics. 2014 Aug 15;30(16):2386-8.
33	Divergent signaling via SUMO modification: potential for CFTR modulation. Am J Physiol Cell Physiol. 2016 Feb 1;310(3):C175-80.
34	Cystic fibrosis transmembrane conductance regulator degradation: cross-talk between the ubiquitylation and SUMOylation pathways. FEBS J. 2013 Sep;280(18):4430-8.
35	Regulation of glutamate transporter trafficking by Nedd4-2 in a Parkinson's disease model. Cell Death Dis. 2017 Feb 2;8(2):e2574.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.

Detail Information of Post-Translational Modifications

Visitor Map

Correspondence